Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dilmurodjon Eshmuminov

Showing results (1-10 of 52) with videos related to

Pageof 6
Sort By:
Annals of Surgical Oncology|March 8, 2017
Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPECMarcel André Schneider, Dilmurodjon Eshmuminov, Kuno Lehmann
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 27, 2023
Liver transplantation as an alternative for the treatment of neuroendocrine liver metastasis: Appraisal of the current evidencePhilip C Müller, Matthias Pfister, Dilmurodjon Eshmuminov, et al.
Cancers|March 25, 2022
Orchestrating Treatment Modalities in Metastatic Pancreatic Neuroendocrine Tumors-Need for a ConductorAlexander R Siebenhüner, Melanie Langheinrich, Juliane Friemel, et al.
World Journal of Surgical Oncology|August 18, 2021
Gastric cancer with positive peritoneal cytology: survival benefit after induction chemotherapy and conversion to negative peritoneal cytologyMassimiliano Valletti, Dilmurodjon Eshmuminov, Nicola Gnecco, et al.
Obesity Surgery|January 8, 2019
The Impact of Roux-en-Y Gastric Bypass on Bone Remodeling Expressed by the P1NP/βCTX Ratio: a Single-Center Prospective Cohort StudyMarkus K Muller, Daniel Gero, Daniela Reitnauer, et al.
World Journal of Surgical Oncology|January 11, 2023
Serum procalcitonin improves diagnosis of infectious complications after CRS/HIPECLilian Roth, Dilmurodjon Eshmuminov, Linda Russo, et al.
World Journal of Surgery|December 17, 2015
Where Oncologic and Surgical Complication Scoring Systems Collide: Time for a New Consensus for CRS/HIPECKuno Lehmann, Dilmurodjon Eshmuminov, Ksenija Slankamenac, et al.
Updates in Surgery|April 4, 2023
Minimally invasive surgery and liver transplantation: is it a safe, feasible, and effective approach?Víctor López-López, María Ángeles Martínez-Serrano, Juan José Ruiz-Manzanera, et al.
Annals of Surgery|October 9, 2019
Novel Real-time Prediction of Liver Graft Function During Hypothermic Oxygenated Machine Perfusion Before Liver TransplantationXavier Muller, Andrea Schlegel, Philipp Kron, et al.
BMC Cancer|May 11, 2018
<sup>18</sup>FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort studyPaul M Schneider, Dilmurodjon Eshmuminov, Tamara Rordorf, et al.
Pageof 6

Showing results (1-10 of 52) with videos related to

Sort By:
Pageof 6
Annals of Surgical Oncology|March 8, 2017
Major Postoperative Complications Are a Risk Factor for Impaired Survival after CRS/HIPECMarcel André Schneider, Dilmurodjon Eshmuminov, Kuno Lehmann
Hepatobiliary & Pancreatic Diseases International : HBPD INT|August 27, 2023
Liver transplantation as an alternative for the treatment of neuroendocrine liver metastasis: Appraisal of the current evidencePhilip C Müller, Matthias Pfister, Dilmurodjon Eshmuminov, et al.
Cancers|March 25, 2022
Orchestrating Treatment Modalities in Metastatic Pancreatic Neuroendocrine Tumors-Need for a ConductorAlexander R Siebenhüner, Melanie Langheinrich, Juliane Friemel, et al.
World Journal of Surgical Oncology|August 18, 2021
Gastric cancer with positive peritoneal cytology: survival benefit after induction chemotherapy and conversion to negative peritoneal cytologyMassimiliano Valletti, Dilmurodjon Eshmuminov, Nicola Gnecco, et al.
Obesity Surgery|January 8, 2019
The Impact of Roux-en-Y Gastric Bypass on Bone Remodeling Expressed by the P1NP/βCTX Ratio: a Single-Center Prospective Cohort StudyMarkus K Muller, Daniel Gero, Daniela Reitnauer, et al.
World Journal of Surgical Oncology|January 11, 2023
Serum procalcitonin improves diagnosis of infectious complications after CRS/HIPECLilian Roth, Dilmurodjon Eshmuminov, Linda Russo, et al.
World Journal of Surgery|December 17, 2015
Where Oncologic and Surgical Complication Scoring Systems Collide: Time for a New Consensus for CRS/HIPECKuno Lehmann, Dilmurodjon Eshmuminov, Ksenija Slankamenac, et al.
Updates in Surgery|April 4, 2023
Minimally invasive surgery and liver transplantation: is it a safe, feasible, and effective approach?Víctor López-López, María Ángeles Martínez-Serrano, Juan José Ruiz-Manzanera, et al.
Annals of Surgery|October 9, 2019
Novel Real-time Prediction of Liver Graft Function During Hypothermic Oxygenated Machine Perfusion Before Liver TransplantationXavier Muller, Andrea Schlegel, Philipp Kron, et al.
BMC Cancer|May 11, 2018
<sup>18</sup>FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort studyPaul M Schneider, Dilmurodjon Eshmuminov, Tamara Rordorf, et al.
Pageof 6